Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Proteins and Peptides

Recombinant Human TNFRSF11B/Osteoprotegerin Protein

Product Sizes
10 ug
£115.00
RP00180-10UG
20 ug
£145.00
RP00180-20UG
50 ug
£193.00
RP00180-50UG
100 ug
£276.00
RP00180-100UG
About this Product
SKU:
RP00180
Additional Names:
TNFRSF11B, OCIF, OPG, PDB5, TR1, TNF receptor superfamily member 11b,Osteoprotegerin,OCIF,OPG,PDB5,TR1
Extra Details:
Recombinant Human TNFRSF11B/Osteoprotegerin Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Glu22-Leu401) of human Osteoprotegerin/TNFRSF11B (Accession #NP_002537.3) fused with a 6xHis tag at the C-terminus.
Formulation:
Lyophilized from a 0.22 um filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation.
Immunogen:
Glu22-Leu401
Molecular Weight:
44.46 kDa
Physical State:
Lyophilized
Purity:
≥ 95 % as determined by SDS-PAGE;≥95 %
Sequence:
ETFPPKYLHYDEETSHQLLCDKCPPGTYLKQHCTAKWKTVCAPCPDHYYTDSWHTSDECLYCSPVCKELQYVKQECNRTHNRVCECKEGRYLEIEFCLKHRSCPPGFGVVQAGTPERNTVCKRCPDGFFSNETSSKAPCRKHTNCSVFGLLLTQKGNATHDNICSGNSESTQKCGIDVTLCEEAFFRFAVPTKFTPNWLSVLVDNLPGTKVNAESVERIKRQHSSQEQTFQLLKLWKHQNKDQDIVKKIIQDIDLCENSVQRHIGHANLTFEQLRSLMESLPGKKVGAEDIEKTIKACKPSDQILKLLSLWRIKNGDQDTLKGLMHALKHSKTYHFPKTVTQSLKKTIRFLHSFTMYKLYQKLFLEMIGNQVQSVKISCL
Shipping Conditions:
Blue Ice
Storage Conditions:
-20[o]C reconstituted. Avoid freeze/thaw cycles., 2-8[o]C reconstituted., -20[o]C/-70[o]C lyophilized. Avoid freeze/thaw cycles.
Supplier:
ABclonal Technology
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Recombinant Proteins
Recombinant Human TNFRSF11B/Osteoprotegerin Protein was determined by SDS-PAGE under reducing conditions with Coomassie Blue.
The purity of Human Osteoprotegerin/TNFRSF11B Protein (Cat.RP00180) was greater than 95% as determined by SEC-HPLC.
Immobilized Recombinant human TNFRSF11B at 2 ug/mL (100 uL/well) can bind Recombinant human TNFSF11 with a linear range of 2-8 ng/mL.
Recombinant Human TNFRSF11B inhibit TRAIL-mediated cytotoxicity using L-929 mouse fibroblast cells treated with TRAIL. The ED50 for this effect is 28.5-114 pg/mL in the presence of 20 ng/mL Recombinant Human TRAIL/TNFSF10.